Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.68 |
| ▸ | CYP11B1 | P15538 | 6/20 | 0.59 |
| ▸ | CYP11B2 | P19099 | 6/20 | 0.59 |
| ▸ | TNF | P01375 | 1/20 | 0.59 |
| ▸ | HTT | P42858 | 4/20 | 0.56 |
| ▸ | LMNA | P02545 | 4/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.54 |
| ▸ | EGLN3 | Q9H6Z9 | 1/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.50 |
| ▸ | PKM | P14618 | 1/20 | 0.50 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.50 |
| ▸ | FDPS | P14324 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11543374 | 0.84 | TDP1 (0.53) | TDP1CYP11B1CYP11B2TNFHTT | |
| SCHEMBL9416591 | 0.82 | FDPS (0.61) | TDP1CYP11B1CYP11B2TNFHTT | |
| SCHEMBL1708839 | 0.82 | TDP1 (0.70) | TDP1CYP11B1CYP11B2TNFHTT | |
| SCHEMBL19911315 | 0.81 | TDP1 (0.50) | TDP1CYP11B1CYP11B2TNFHTT | |
| SCHEMBL6442808 | 0.81 | TDP1 (1.00) | TDP1CYP11B1CYP11B2TNFHTT | |
| SCHEMBL30564238 | 0.81 | TDP1 (0.76) | TDP1CYP11B1CYP11B2TNFHTT | |
| SCHEMBL6794361 | 0.81 | TDP1 (0.76) | TDP1CYP11B1CYP11B2TNFHTT | |
| SCHEMBL11536277 | 0.80 | SMN1; SMN2 (0.49) | TDP1CYP11B1CYP11B2TNFHTT | |
| SCHEMBL3966477 | 0.79 | TDP1 (0.73) | TDP1CYP11B1CYP11B2TNFHTT | |
| SCHEMBL11092609 | 0.78 | TDP1 (0.66) | TDP1CYP11B1CYP11B2TNFHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240327549-A1 | METAL-CONTAINING POLYMERS FOR MASS CYTOMETRY | STANDARD BIOTOOLS CANADA INC. (CA) | 2024-10-03 | — | — | US | disclosed |
| EP-4367164-A1 | METAL-CONTAINING POLYMERS FOR MASS CYTOMETRY | The Governing Council of the University of Toronto (CA) | 2024-05-15 | — | — | EP | disclosed |
| WO-2023279211-A1 | METAL-CONTAINING POLYMERS FOR MASS CYTOMETRY | THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO (CA) | 2023-01-12 | — | — | WO | disclosed |
| US-8563738-B2 | Ligands for copper-catalyzed azide-alkyne cycloaddition reactions | THE SCRIPPS RESEARCH INSTITUTE (US) | 2013-10-22 | — | — | US | disclosed |
| US-20100197871-A1 | LIGANDS FOR COPPER-CATALYZED AZIDE-ALKYNE CYCLOADDITION REACTIONS | THE SCRIPPS RESEARCH INSTITUTE | 2010-08-05 | — | — | US | disclosed |
| WO-2009038685-A1 | LIGANDS FOR COPPER-CATALYZED AZIDE-ALKYNE CYCLOADDITION REACTIONS | THE SCRIPPS RESEARCH INSTITUTE (US) | 2009-03-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100197871-A1 | LIGANDS FOR COPPER-CATALYZED AZIDE-ALKYNE CYCLOADDITION REACTIONS | AOC2, AOC1, AOC3 | TDP1 3666/4885CYP11B1 1535/4885CYP11B2 1442/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.